The case for early rhythm control, achieved by ablation or cardioversion, in most patients with atrial fibrillation (AF) is mechanistically stronger with a new study suggesting the strategy can ...
At 1 year, nearly 80% of patients with atrial fibrillation treated with an FDA-approved spherical pulsed field ablation ...
Background Mechanical compression from the ascending aorta on the left atrial anterior wall (LAAW) can cause low voltage ...
Compared with medical therapy, rhythm control with catheter ablation is associated with lower risk of ischemic stroke after 30 days, as well as less mortality and heart failure (HF) hospitalization, ...
INDIANAPOLIS (WISH) — In the next two decades, up to 60 million people will get atrial fibrillation or A-fib. It doesn’t always show symptoms but people with it have a five-times increased risk of a ...
Cardioversion is a medical procedure to correct a heartbeat that is irregular or too fast. It can involve risks and side effects but is generally safe and effective. Doctors primarily use ...
Previously, patients with advanced atrial fibrillation (AF/AFib) had limited treatment choices. Since February 2024, West ...
Please provide your email address to receive an email when new articles are posted on . Improved atrial fibrillation ablation strategies and technologies during the past decade are associated with a ...
For the first time, the US Food and Drug Administration has approved a pulsed-field ablation (PFA) system for the treatment of atrial fibrillation (AF): the PulseSelect PFA system. Device maker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results